| # | Drug | Count |
|---|---|---|
| 0 | UPADACITINIB | 23 |
| 1 | ADALIMUMAB | 15 |
| 2 | RISANKIZUMAB-RZAA | 9 |
| 3 | ETANERCEPT | 5 |
| 4 | FOLIC ACID | 5 |
| 5 | ALENDRONATE SODIUM | 4 |
| 6 | ASPIRIN | 4 |
| 7 | ASPIRIN 325 MG | 4 |
| 8 | ASPIRIN 81 MG | 4 |
| 9 | DIAZEPAM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM CITRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | 1 | 0.0323 |
| 1 | VANDETANIB | 1 | 0.0006 |
| 2 | CEFADROXIL | 1 | 0.0005 |
| 3 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 6 | UPADACITINIB | 23 | 0.0003 |
| 7 | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | 0.0002 |
| 8 | BISMUTH SUBSALICYLATE | 1 | 0.0002 |
| 9 | POTASSIUM CITRATE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 23 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 2 | Interleukin-23 Antagonist [EPC] | 9 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 9 |
| 4 | Benzodiazepine [EPC] | 8 |
| 5 | Vitamin B12 [EPC] | 8 |
| 6 | Corticosteroid [EPC] | 7 |
| 7 | Vitamin C [EPC] | 7 |
| 8 | Vitamin D [EPC] | 6 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Bismuth [EPC] | 1 | 0.0002 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Janus Kinase Inhibitor [EPC] | 23 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 5 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 6 | Interleukin-23 Antagonist [EPC] | 9 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |